227 related articles for article (PubMed ID: 34632870)
1. Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.
Yang Z; Wang J; Chen C; Sun P; Yu Y
Technol Cancer Res Treat; 2021; 20():15330338211046432. PubMed ID: 34632870
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
3. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
[TBL] [Abstract][Full Text] [Related]
4. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
[TBL] [Abstract][Full Text] [Related]
5. [Study on the mechanism of miR-497-induced laryngeal squamous cell carcinoma growth inhibition by targeting CDK6].
Niu JT; Liu SG; Yan P; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 54(2):126-132. PubMed ID: 30776865
[No Abstract] [Full Text] [Related]
6. Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis.
Franz L; Alessandrini L; Ottaviano G; di Carlo R; Fasanaro E; Ramacciotti G; Contro G; Marioni G
Pathol Res Pract; 2020 Sep; 216(9):153120. PubMed ID: 32825972
[TBL] [Abstract][Full Text] [Related]
7. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal.
Wang M; Wu CP; Pan JY; Zheng WW; Cao XJ; Fan GK
PLoS One; 2015; 10(2):e0117405. PubMed ID: 25658113
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
[TBL] [Abstract][Full Text] [Related]
10. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
[TBL] [Abstract][Full Text] [Related]
11. [Effects of downregulation of HDAC6 expression on cell cycle, proliferation and migration of laryngeal squamous cell carcinoma].
Yuan LL; Wang F; Li SL; Lou WH; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):430-5. PubMed ID: 22967444
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma.
Dai MY; Fang F; Zou Y; Yi X; Ding YJ; Chen C; Tao ZZ; Chen SM
Oncol Rep; 2015 Dec; 34(6):3111-9. PubMed ID: 26398771
[TBL] [Abstract][Full Text] [Related]
13. Copy number gains of the putative CRKL oncogene in laryngeal squamous cell carcinoma result in strong nuclear expression of the protein and influence cell proliferation and migration.
Kostrzewska-Poczekaj M; Bednarek K; Jarmuz-Szymczak M; Bodnar M; Filas V; Marszalek A; Bartochowska A; Grenman R; Kiwerska K; Szyfter K; Giefing M
Sci Rep; 2020 Jan; 10(1):24. PubMed ID: 31913340
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma.
Zhao L; Li P; Zhao L; Wang M; Tong D; Meng Z; Zhang Q; Li Q; Zhang F
J Cell Biochem; 2020 Feb; 121(2):1855-1869. PubMed ID: 31633227
[TBL] [Abstract][Full Text] [Related]
15. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
16. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
[TBL] [Abstract][Full Text] [Related]
17. Lack of miR-1246 in small extracellular vesicle blunts tumorigenesis of laryngeal carcinoma cells by regulating Cyclin G2.
Huang Q; Hsueh CY; Guo Y; Wu XF; Li JY; Zhou L
IUBMB Life; 2020 Jul; 72(7):1491-1503. PubMed ID: 32196930
[TBL] [Abstract][Full Text] [Related]
18. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
20. PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Kawasaki K; Noma K; Kato T; Ohara T; Tanabe S; Takeda Y; Matsumoto H; Nishimura S; Kunitomo T; Akai M; Kobayashi T; Nishiwaki N; Kashima H; Maeda N; Kikuchi S; Tazawa H; Shirakawa Y; Fujiwara T
Cancer Immunol Immunother; 2023 Nov; 72(11):3787-3802. PubMed ID: 37668710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]